BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 11955366)

  • 1. [Proliferating activity and differentiation between peripheral cells and central cells in ameloblastoma].
    Liu J; Wang S; Chen X; Li Y
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2002 Jan; 37(1):62-4. PubMed ID: 11955366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proliferating cell nuclear antigen and Ki67 immunoreactivity in ameloblastomas.
    Meer S; Galpin JS; Altini M; Coleman H; Ali H
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 Feb; 95(2):213-21. PubMed ID: 12582363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A immunohistochemical study of the peripheral ameloblastoma.
    Kishino M; Murakami S; Yuki M; Iida S; Ogawa Y; Kogo M; Toyosawa S
    Oral Dis; 2007 Nov; 13(6):575-80. PubMed ID: 17944675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of proliferating cell nuclear antigen (PCNA) and Ki-67 in unicystic ameloblastoma.
    Li TJ; Browne RM; Matthews JB
    Histopathology; 1995 Mar; 26(3):219-28. PubMed ID: 7797199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical investigation of epidermal growth factor receptor expression in ameloblastomas.
    Ueno S; Miyagawa T; Kaji R; Mushimoto K; Shirasu R
    J Pathol; 1994 May; 173(1):33-8. PubMed ID: 7931835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of proliferating cell nuclear antigen expression in odontogenic keratocyst and ameloblastoma: an immunohistochemical study.
    Takahashi H; Fujita S; Yamabe S; Moriishi T; Okabe H; Tajima Y; Mizuno A
    Anal Cell Pathol; 1998; 16(4):185-92. PubMed ID: 9762365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of Ki-67 antigen in ameloblastoma and its clinical significance].
    Han B; Li L; Wang H
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2003 Apr; 21(2):153-4. PubMed ID: 12838707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression of telomerase activity and cyclin A in ameloblastoma].
    Zhong M; Yue YL; Wang J; Wang ZY
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2003 Jul; 38(4):257-60. PubMed ID: 12930651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical evaluation of PCNA and Ki-67 in ameloblastoma.
    Sandra F; Mitsuyasu T; Nakamura N; Shiratsuchi Y; Ohishi M
    Oral Oncol; 2001 Feb; 37(2):193-8. PubMed ID: 11167148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histochemistry of Ki-67 antigen in ameloblastomas.
    Nagao Y; Wato M; Tanaka A
    J Osaka Dent Univ; 1999 Oct; 33(2):53-7. PubMed ID: 10863475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Quantitative study of the cellular nuclear DNA contents in odontogenic cysts and ameloblastoma].
    Wang E; Yu G; Zhang Z; Gao Y
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2002 Nov; 37(6):421-4. PubMed ID: 12641953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical detection of proliferating cell nuclear antigen (PCNA) in 23 cases of ameloblastoma.
    Funaoka K; Arisue M; Kobayashi I; Iizuka T; Kohgo T; Amemiya A; Totsuka Y
    Eur J Cancer B Oral Oncol; 1996 Sep; 32B(5):328-32. PubMed ID: 8944836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proliferating-cell nuclear antigen (PCNA) as an independent prognostic marker in patients after prostatectomy: a comparison of PCNA and Ki-67.
    Taftachi R; Ayhan A; Ekici S; Ergen A; Ozen H
    BJU Int; 2005 Mar; 95(4):650-4. PubMed ID: 15705097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PCNA-LII, Ki-67 immunostaining, p53 activity and histopathological variables in predicting the clinical outcome in patients with parathyroid carcinoma.
    Lumachi F; Ermani M; Marino F; Iacobone M; Baldessin M; Cappuzzo G; Zanella S; Favia G
    Anticancer Res; 2006; 26(2A):1305-8. PubMed ID: 16619538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of Ki-67 and PCNA as proliferating markers in prostate cancer.
    Sulik M; Guzińska-Ustymowicz K
    Rocz Akad Med Bialymst; 2002; 47():262-9. PubMed ID: 12533969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of proliferating markers Ki-67, PCNA in gastric cancers.
    Czyzewska J; Guzińska-Ustymowicz K; Lebelt A; Zalewski B; Kemona A
    Rocz Akad Med Bialymst; 2004; 49 Suppl 1():64-6. PubMed ID: 15638377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A study of histopathology and cell proliferation in calcifying odontogenic cyst].
    Lei A; Wang S; Su Q
    Zhonghua Kou Qiang Yi Xue Za Zhi; 1998 Jul; 33(4):207-9. PubMed ID: 11774633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical detection of alpha 1-antitrypsin, alpha 1-antichymotrypsin, transferrin and ferritin in ameloblastoma.
    Takahashi H; Tsuda N; Yamabe S; Fujita S; Okabe H
    Anal Cell Pathol; 1995 Sep; 9(2):135-50. PubMed ID: 7492517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of apoptosis-related proteins in various cellular components of ameloblastomas.
    Luo HY; Yu SF; Li TJ
    Int J Oral Maxillofac Surg; 2006 Aug; 35(8):750-5. PubMed ID: 16690252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokeratins expression of constituting cells in ameloblastoma.
    Fukumashi K; Enokiya Y; Inoue T
    Bull Tokyo Dent Coll; 2002 Feb; 43(1):13-21. PubMed ID: 12013821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.